AI assistant
ABBOTT LABORATORIES — Director's Dealing 2012
Feb 8, 2012
29777_dirs_2012-02-08_f07d5f07-6bc2-4b42-87e8-eea0bcb82e53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2012-02-01
Reporting Person: Murray Corlis D (Senior Vice President)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 32383 | Direct |
| Common shares without par value | 6936 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Option (right to buy) | $53.625 | 2012-02-14 | Common shares (1890) | Direct | |
| Option (right to buy) | $53.625 | 2012-02-14 | Common shares (481) | Direct | |
| Option (right to buy) | $52.54 | 2017-02-15 | Common shares (1900) | Direct | |
| Option (right to buy) | $52.54 | 2017-02-15 | Common shares (1900) | Direct | |
| Option (right to buy) | $55.56 | 2018-02-14 | Common shares (1934) | Direct | |
| Option (right to buy) | $55.56 | 2018-02-14 | Common shares (1933) | Direct | |
| Option (right to buy) | $55.56 | 2018-02-14 | Common shares (1933) | Direct | |
| Option (right to buy) | $54.14 | 2019-02-19 | Common shares (4267) | Direct | |
| Option (right to buy) | $54.14 | 2019-02-19 | Common shares (4267) | Direct | |
| Option (right to buy) | $54.14 | 2019-02-19 | Common shares (4266) | Direct | |
| Option (right to buy) | $54.50 | 2020-02-18 | Common shares (3234) | Direct | |
| Option (right to buy) | $54.50 | 2020-02-18 | Common shares (3233) | Direct | |
| Option (right to buy) | $54.50 | 2020-02-18 | Common shares (3233) | Direct | |
| Option (right to buy) | $46.60 | 2021-02-17 | Common shares (3534) | Direct | |
| Option (right to buy) | $46.60 | 2021-02-17 | Common shares (3533) | Direct | |
| Option (right to buy) | $46.60 | 2021-02-17 | Common shares (3533) | Direct |
Footnotes
F1: Balance in the Abbott Laboratories Stock Retirement Trust as of February 1, 2012.
F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.
F3: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.
F4: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.